Better Therapeutics, Inc. Profile Avatar - Palmy Investing

Better Therapeutics, Inc.

Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in deve…

Biotechnology
US, San Francisco [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Better Therapeutics, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Better Therapeutics, Inc. can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of Better Therapeutics, Inc..

If you want to see a demo, head over to the financial segments of AAPL

End of BTTX's Analysis
CIK: 1832415 CUSIP: 08773T104 ISIN: US08773T1043 LEI: - UEI: -
Secondary Listings
BTTX has no secondary listings inside our databases.